$FRX Recent News Earnings boost Micron, drag on Container

New Post Public Reply Private Reply Replies (0) Message Board

Jan 11, 2014 at 9:19 PM

$FRX Recent News

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
U.S. stocks end lower after Fed minutes 4:24 p.m. Jan. 8, 2014 - Anora Mahmudova
Stock market live blog (recap): Dow, S&P 500 end lower after Fed minutes 4:04 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Forest shares see double-digit gains following Aptalis purchase 11:03 a.m. Jan. 8, 2014 - Russ Britt
Forest Laboratories acquires Aptalis for $2.9 bln 7:50 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Forest Laboratories acquires Aptalis for $2.9 bln 7:45 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Facebook, Twitter, Yahoo are stocks to watch 1:57 p.m. Dec. 24, 2013 - Wallace Witkowski
Stocking stuffer stocks for 2014 10:52 a.m. Dec. 23, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Dow set to open below 16,000; Apple rises 8:53 a.m. Dec. 3, 2013 - William L. Watts
Forest Laboratories to cut 9% of workforce 11:39 p.m. Dec. 2, 2013 - MarketWatch.com
EBay outperforms Amazon on Cyber Monday 4:16 p.m. Dec. 2, 2013 - Sue Chang
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - Russ Britt
Forest Labs to cut $500 mln in costs, R&D 9:55 a.m. Dec. 2, 2013 - MarketWatch.com
Apple snaps winning streak; Netflix rewinds 3:59 p.m. Oct. 22, 2013 - Sue Chang
Changing of the guard at Forest Labs placates Icahn — for now 3:50 p.m. Sept. 10, 2013 - Russ Britt
Forest Labs Fetzima Gets FDA OK on depression drug 8:06 a.m. July 26, 2013 - MarketWatch.com
Forest Labs investors see the light; swing shares to a gain near close 2:38 p.m. July 23, 2013 - Russ Britt
Centene, Forest each beat earnings views, but diverge in market woods 10:16 a.m. July 23, 2013 - Russ Britt
Forest Labs net falls 58% on lower Lexapro sales 7:06 a.m. July 23, 2013 - MarketWatch.com

Ironwood Up on Job Cut Plans - Analyst Blog 6:30 p.m. Jan. 10, 2014 - Zacks.com
Aegerion Gives Preliminary 2013 Update - Analyst Blog 5:10 p.m. Jan. 10, 2014 - Zacks.com
ENDP Agrees to Sell HealthTronics Unit - Analyst Blog 11:40 a.m. Jan. 10, 2014 - Zacks.com
SA PRO: Top Long And Short Ideas, Thursday January 9 7:30 a.m. Jan. 10, 2014 - Seeking Alpha
NuPathe Soars on Teva Offer - Analyst Blog 3:05 p.m. Jan. 9, 2014 - Zacks.com
Forest Labs Soars on Aptalis Deal - Analyst Blog 1:10 p.m. Jan. 9, 2014 - Zacks.com
Update on AMAG's Feraheme - Analyst Blog 1:00 p.m. Jan. 9, 2014 - Zacks.com
Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog 12:10 p.m. Jan. 9, 2014 - Zacks.com
NPSP Provides Rosy Gattex Outlook, Shares up - Analyst Blog 11:40 a.m. Jan. 9, 2014 - Zacks.com
Forest Branches Out With $2.9B Purchase of Rival 9:48 a.m. Jan. 9, 2014 - Barrons.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Jan. 9, 2014 - Seeking Alpha
New Data on Pacira's Exparel - Analyst Blog 6:11 p.m. Jan. 8, 2014 - Zacks.com
Oculus Introduces Two Products - Analyst Blog 5:10 p.m. Jan. 8, 2014 - Zacks.com
AZN and Horizon Discovery Ink Deal - Analyst Blog 5:02 p.m. Jan. 8, 2014 - Zacks.com
Affymetrix Up on Upbeat Rev Guidance - Analyst Blog 4:45 p.m. Jan. 8, 2014 - Zacks.com
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Provides Strong Guidance, Shares Up - Analyst Blog 2:20 p.m. Jan. 8, 2014 - Zacks.com
The Deal: Forest Widens Business, Pays $2.9 Billion for Aptalis 2:06 p.m. Jan. 8, 2014 - TheStreet.com
Abraxane Label Expansion Lifts Celgene - Analyst Blog 11:30 a.m. Jan. 8, 2014 - Zacks.com
Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo 10:24 a.m. Jan. 8, 2014 - Investors Business Daily

Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704 9:00 a.m. Jan. 9, 2014 - PR Newswire
Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of TRV027 for Acute Heart Failure 6:59 a.m. Jan. 9, 2014 - BusinessWire
Aptalis to be Acquired by Forest Laboratories for $2.9 Billion 7:36 a.m. Jan. 8, 2014 - BusinessWire
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash 7:29 a.m. Jan. 8, 2014 - BusinessWire
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
moksha8 files for regulatory approval of Viibryd® and Colobreathe in Brazil and amends alliance with Forest Laboratories 8:00 a.m. Jan. 6, 2014 - PR Newswire
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 3:59 p.m. Jan. 2, 2014 - BusinessWire
Drug Availability, Clinical Trial Partnerships, Labeling Discussions, Stock Updates, and Credit Facilities - Research Report on Forest Laboratories, Oxygen Biotherapeutics, Alimera, pSivida and AcelRx 8:00 a.m. Dec. 24, 2013 - PR Newswire
Forest Announces New FETZIMA(TM) (levomilnacipran ER capsules) Now Available in Pharmacies Throughout U.S. 8:00 a.m. Dec. 19, 2013 - BusinessWire
Stock Price Updates, Dividends Declaration, and Appointments in Executive Leadership Team - Research Report on Humana, Illumina, Forest Laboratories, Stryker, and Unilife 8:00 a.m. Dec. 16, 2013 - PR Newswire
Forest Laboratories Announces Appointments to its Executive Team 9:00 a.m. Dec. 9, 2013 - BusinessWire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Forest Laboratories, Inc. Upsizes and Prices Offering of $1.2 Billion of Senior Notes Due 2021 4:36 p.m. Dec. 5, 2013 - BusinessWire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
Forest Laboratories, Inc. Announces Private Placement of Senior Notes and Amendment to Existing $750 Million Revolver 8:30 a.m. Dec. 2, 2013 - BusinessWire
Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock 8:30 a.m. Dec. 2, 2013 - BusinessWire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine 2:00 a.m. Nov. 21, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veho's Role in Redefining Beauty E-Commerce Delivery

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Sacrifice Unending: 9/11's Lingering Health Toll

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Law Firm Gains Strength with Strategic New Hires

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

CUBEX Lights Up Veterinary Care with Mini Essential

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Midlife ADHD in Women: New Challenges and Solutions

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

ABC Honors 2026 Spirit of the Heart Leaders

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...